Invention Grant
- Patent Title: Heterocyclic amide compounds useful as kinase inhibitors
- Patent Title (中): 用作激酶抑制剂的杂环酰胺化合物
-
Application No.: US13038488Application Date: 2011-03-02
-
Publication No.: US08404689B2Publication Date: 2013-03-26
- Inventor: Stephen T. Wrobleski , Jagabandhu Das , T. G. Murali Dhar , Alaric J. Dyckman , John Hynes , Katerina Leftheris , James Lin , Shuqun Lin
- Applicant: Stephen T. Wrobleski , Jagabandhu Das , T. G. Murali Dhar , Alaric J. Dyckman , John Hynes , Katerina Leftheris , James Lin , Shuqun Lin
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Laurelee A. Duncan; Pamela A. Mingo; Gary A. Greenblatt
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/445 ; A61K31/404 ; C07D209/04 ; C07D211/06 ; C07D241/04
Abstract:
A compound of Formula I and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase.
Public/Granted literature
- US20110160207A1 HETEROCYCLIC AMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2011-06-30
Information query
